UNSPSC 51334200: Antipsychotic thiepins

Antipsychotic drugs made from seven-membered sulfur compounds with six carbon atoms and one sulfur atom.

UNSPSC 51334200 Antipsychotic thiepins is a Class code with minimal direct alignment to the recent state and local solicitation activity indexed under it. The code nominally covers antipsychotic medications in the thiepin chemical family, but the three most recent opportunities tagged to this code procure naloxone and drug deactivation systems, direct-to-manufacturer prescription fulfillment capabilities, and generic multi-source pharmaceuticals and over-the-counter products—none of which are antipsychotic thiepins. The mismatch suggests either tagging error in the source records or that state and local procurement offices are using this code to capture a broader pharmaceutical-supply family than the code name alone indicates. Issuing bodies span state health agencies (Texas Health and Human Services Commission), county health departments (Seminole County, Florida), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities in Minnesota, Oregon, and other participating jurisdictions).

Recent activity concentrates in the Southeast and Upper Midwest. Seminole County, Florida issued an IFB on June 30, 2026 (due July 26, 2023—a date discrepancy in the source) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, using an e-Procurement Portal submission process and requiring drug-free workplace certification and E-Verify compliance. The Texas Health and Human Services Commission posted an RFI on April 3, 2026 seeking vendor information on direct-to-manufacturer prescription programs to inform future procurement strategy, with no award value specified at the exploratory stage. The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative, issued an RFP posted January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers, with effective date July 1, 2026, requiring cGMP and Drug Supply Chain Security Act compliance, $5 million commercial general liability insurance, and pricing weighted 75 percent in evaluation. None of these three solicitations directly match antipsychotic thiepin procurement; the code shows little relevant recent activity for this specific drug family.